OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Pharmaceutical Research and Manufacturers of America":

"… D. Bennett, senior vice president of communications and public affairs at Pharmaceutical Research and Manufacturers of America (PhRMA), wrote within hours of the speech: “The President’s proposal …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "Barack Obama":

"… o the Federal Election Commission for telephone calls supporting President Barack Obama and Sen. Bob Casey, D-Pa., in October.When the Center for Public Integrity …"

Federal regulators have failed to act on toxic chemical, report says

By Chris Hamby

Regulators have done little to protect the public from BPA, critics say

Report faults Medicare controls on widely abused drugs

By Joe Eaton

Beneficiaries easily went to multiple doctors for hydrocodone and oxycodone

Excerpts from this story referencing "Medicaid":

"… l practitioners in the same year.The GAO said the Centers for Medicare and Medicaid Services (CMS) has systems in place to identify inappropriate drug use by …"

"… l abuses.”  Witnesses from the GAO and the Centers for Medicare and Medicaid Services are expected to testify on the issue at Senate subcommittee heari …"

Inspectors struggle to keep up with flood of imports

By Brad Racino

Food imports approved for use in the U.S. in an unexpected way

Excerpts from this story referencing "U.S. House of Representatives":

"… cuts spending in an effort to reduce the nation’s debt. A measure in the U.S. House of Representatives would cut $285 million from the agency’s 2012 budget, with $35 million c …"

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA needs more power to police recalls of imported foods

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

During Mitch Daniels’ decade at Eli Lilly, the drug giant paid billions in fines and settled thousands of lawsuits

By Joanne Kenen and Rochelle Sharpe

Eli Lilly paid billions in fines, settled thousands of lawsuits while Daniels was an executive at the drug giant

Excerpts from this story referencing "San Diego":

"… e was taking Zyprexa. "I just thought his appetite had increased," saidthe San Diego woman. She didn’t realize her son had developed severe hyperglycemia, ab …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Drug Enforcement Administration":

"… t,” he said.Mark Caverly, chief of the liaison and policy section of the Drug Enforcement Administration’s Office of Diversion Control, said the root of the problem probably res …"

"… ier directory is available. For a fee, net surfers can also gain access to Drug Enforcement Administration prescriber numbers from a website run by a private company in partnership …"

FDA criticized for accepting free help from company that later won generic OK

By Laurel Adams

The Food and Drug Administration last month issued guidelines for agency staff to follow when drugmakers offer free help during emergencies

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Excerpts from this story referencing "U.S. Food and Drug Administration":

"… s of a surgeon, it goes through a long and complex approval process by the U.S. Food and Drug Administration.A new drug, for instance, goes through laboratory testing and animal studi …"

"… ion about clinical trials, including results, available to the public. The U.S. Food and Drug Administration Amendments Act of 2007, which went into effect in September 2008, requires …"

"… linical trials data and results for new drugs, biologics and devicesWhere: U.S. Food and Drug AdministrationAvailability: Sporadic, not centralized, and mostly inaccessibleFormat: N/A …"

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Excerpts from this story referencing "U.S. Food and Drug Administration":

"… id Chinese seafood.All these recent problems fell within the domain of the U.S. Food and Drug Administration, which shares food inspection responsibilities with the U.S. Department of …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Excerpts from this story referencing "U.S. Food and Drug Administration":

"… the court enter the consent decree is set for a hearing on January 20. …"

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "Colorado":

"… the digoxin on the market in the United States.Barbara Guthrie of Denver, Colorado, whose husband, James Guthrie died on August 18, 2007, after taking Digite …"

"… ek, filed a wrongful death suit in U.S. District Court for the District of Colorado on August 1st. She claims that Actavis should have known of the dangers of …"

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

Excerpts from this story referencing "U.S. Food and Drug Administration":

"… or drug performance and could help prevent another Vioxx-like debacle. …"

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

PEPFAR policy hinders treatment in generic terms

By M. Asif Ismail

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients

Excerpts from this story referencing "Africa":

"… ocus country programs — those in Côte d'Ivoire, Ethiopia, Rwanda, South Africa, Tanzania and Vietnam — procured virtually no generic ARV drugs last yea …"

"… lamivudine and nevirapine — for approximately $400 per person a year in Africa. The makers of the brand-name drugs had been marketing the medications sep …"

"… ngovernmental groups to make them available for a wider population."All of Africa had 15,000 people covered by the multinational drug companies [before the …"

"… d by the U.S.-based Barr Laboratories and one by Aspen Pharmacare of South Africa.Mahoney said FDA's Office of Generic Drugs had received 42 applications by …"

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "University of Texas":

"… dustry together sponsored more than 100 trips costing roughly $98,000. The University of Texas conducts clinical trials for drug companies, including AstraZeneca and TAP …"

Drug lobby second to none

By M. Asif Ismail

How the pharmaceutical industry gets its way in Washington

Excerpts from this story referencing "U.S. House of Representatives":

"… luding more than 15 former Senators and more than 60 former members of the U.S. House of Representatives. The two trade groups, PhRMA and BIO, are headed by two influential former …"

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Checkbook politics

By Victoria Kreha

Over the last seven years, the pharmaceutical industry has given $150 million in campaign contributions

Excerpts from this story referencing "Center for Responsive Politics":

"… Public Integrity analysis of campaign finance records provided by the Center for Responsive Politics and the Institute on Money in State Politics. Sixty-five percent …"

"… deral campaign contributions, the Center used research by the non-partisan Center for Responsive Politics, based in Washington, D.C. The analysis on state political donations was b …"